NOAH FENCE
Taken or intended
You stick with NAN
Ill stick with PEB
I have not even started researching PEB
Let you know when I have.
Now where were we -ah yes PEB sharetrader post number 33:)
Printable View
Thanks for your concern Skid but I'm all good thanks. We all "DOOR" differently and when I choose to make comparisons, I do it with oranges vs oranges.....can end up messy (& in tears??) otherwise. I focus on researching where my strengths are and leave all the fancy stuff to others and I can unashamedly state I am very happy holding my little wad of PEB!
My original comment was motivated by not wanting to see threads get cross referenced with other threads - for what I think are obvious reasons.
Emotionally involved? Nah .... otherwise I wouldn't have lightened myself of a few PEB back along ... when the ones who didn't "DTOR" wanted to take them off my hands at a nice price.
And, I don't have a gold card either...too young for it and don't need it!
Roll on 2015.
Well others have already done that for you--but we wouldnt want to jinx it by looking at others would we..
Hopefully both will have a good year!
Then I stand corrected dents--You sold when it seemed the time was right--That shows that yours was not a ''hold at any cost'' theory
and thats a good thing IMO.
The only reason I mentioned ''the other'' is in case anyone wanted to go to ''the other'' thread and do research between the two.
Experienced investors do it all the time---Its not ''stepping out''on the wife---just research.
Hell ..I might be buying back in, in the future--unless some in ''the club'' write to the nZX and ban me from buying :eek2:
[QUOTE=Minerbarejet;523607]Crikey now you really have me worried. I was unaware that mysticism through good luck and jinxes ( or is that jinxii) formed part of research in PEB. If it applies to NAN then there is no foretelling what might happen.
Whats this "we" Kemosabi?:)[/QUOT
"WE" is ''the club'' Tonto----C'mon guys you know who ''the club'' is--just go back and read the posts---who comes to the rescue when someone questions something about ''your'' company-- who gets upset (and sometimes bitter when the SP seems to have a mind of its own)--who gloats when the SP rises.
Who gets upset when someone says something that upsets the status quo--that somehow threatens -(thats where the jinx comes in)
Why get aggravated at a comparison ?--its not downgrading the product--mostly just comparing market strategies--some would welcome the research.
You should be content that Mac says theres a 40% profit if you want it--(did you hear that Newbies--easy as that)
I still think PEB is a good company---(just not so sure about that growth curve)
We'll just have to wait and see how it goes with the big outfits --whether they come on board--what kind of a deal they strike--and how it actually translates into sales numbers.
Who knows,maybe Santa is wrapping up a sweet deal at this very moment,in which case there will be
''high fives'' all around the C....ok I wont say it again:D
Let me add some info which might show a more complete picture - thanks to Chalkie's research. http://i.stuff.co.nz/business/opinio...e-share-appeal
And the quote of Lizard makes another cameo appearance. To me the key of what has gone on with PEB lies with a phrase in the second to last sentence. Whilst Matritech and Genomic Health have expensing of R&D done in the USA, PEB has the advantage of R&D done in NZ, which continues to this day as part of the agreement with Otago University Cancer Research.
Here is a little something for Christmas that I havent seen posted as yet.
http://www.otago.ac.nz/otagomagazine...ago080116.html
Cheers
Miner
I find it funny that it's nothing but all good news, flowers and rosy views here on PEB from some posters, yet as soon as things are challenged through another stock (a loose comparison at best), there is nothing but spewing negativity and hate for the stock.
Strange that some of these comments can be applied to PEB, but it is never talked about in this way...
Just remember people, not all comments are equal, and to have that big bag of salt ready to take with every dose!
Can we agree that pissing in a cup is as easy as signing up for a Xero account? Xero and PEB scale with every new customer (better than NAN) because the economies of scale are huge (bigger than NAN's). EPS is the least useful measure to value a start-up. Should company owners gift PEB to the market because EPS is negative? Would you? What matters are debt, cashflow and revenue growth.
The reason we have a lot of friction on this thread aren't thin-skinned bulls. It seems the weakest arguments are repeated the most which distracts from valid criticism. What needs to be said is that economies of scale and a promise don't guarantee a good investment. There is a lot that can go wrong. PEB is a high-risk play and people shouldn't bet money they can't loose. In a functioning market the risk/reward ratios of PEB and NAN should be the same. One could argue that NAN is less risky and therefore preferable. You may disagree with the market and see NAN as the better risk/reward proposition. But you cannot talk away PEB's huge potential.
Seems pretty fair Casino, if being a growth investor as opposed to a value investor is about assessing a stocks position on the risk reward curve and mitigating that risk where possible, than it is difficult to compare two companies directly unless one has absolutely and thoroughly researched both.
Thanks Pietrade though for highlighting NAN, I might have a look at that over the holidays, although I’m not sure it’s generally the right time to be in anything ASX, there’s a reason for the AUD being where it is.
Risk is a perception at the end of the day, most initially assume the worst and then see how far good research may alleviate that risk, and everyone as an individual and at a different spot along in that process. But, at the end of the day perhaps the Oracle could be right too;
"Risk comes from not knowing what you're doing" – Warren Buffet
My point was that NAN and PEB are not directly comparable because one is medtech and the other biotech:
https://atpbio.wordpress.com/2011/09...-from-medtech/
Medtech might be a better fit for some/most but it's silly to criticise a biotech company for not being a medtech company. Scrutiny should be based on whether it is a good or bad biotech play.
To sharetrader posters/readers who have no experience with small biotechs, stay away in bull markets! Most small (bio)techs fail. Wait for a big correction/crash/financial crisis/depression and look for bargains amongst survivors.
Yep, agree that the molecular diagnostic and medical device sectors are different and require different treatments.
I do think though that most growth investors may not probably agree with you that the only way of investing in risk is to wait for a global financial crises to come along.
There are generally always opportunities on the risk reward curve, and successful growth companies will progressively de-risk in steps as they work through R&D milestones, regulatory approvals, commercial roll out milestones, each offering an associated step-up in value as they go.
Some like Hancock’s who have been researching Pacific Edge for 10 years are probably more knowledgeable than most of us in assessing the risk/reward, certainly more so than some of the flippant folk on this thread who research very little but think they know it all.
It’s served him very well too, probably got in with a 10c spread or something like that with all those rights issues along the way, and the company is just now at the beginning of the revenue curve, with at least another five years of potential yet to be taken up.